5Solomon D,Davey D,Kurman R,et al.The 2001 Bethesda System:terminology for reporting results of cervical cytology.JAMA,2002,287:2114-2119.
6Thomas C,Wright Jr.L,Massad S,et al.2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests.American Society for Colposcopy and Cervical Pathology Journal of Lower Genital Tract Disease,2007,11:201-222.
7Thomas C,Wright Jr.L,Massad S,et al.Management of Women With Cervical Intraepithelial Neoplasia or Adenocarcinoma In Situ.American Society for Colposcopy and Cervical Pathology Journal of Lower Genital Tract Disease,2007,11:223-239.
8Cuzick J,Arbyn M,Sankaranarayanan R,et al.Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.Vaccine,2008,26 (Suppl 10):K29-41.
9Naucler P,Ryd W,Tǒrnberg S,et,al.Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.J Natl Cancer Inst,2009,101:88-99.
10Kjaer S,Hφgdall E,Frederiksen K,et al.The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive,cytologically normal women over a 10-year period.Cancer Res,2006,66:10630-10636.
